Cipla’s wholly owned subsidiary -- Cipla (EU), UK, has incorporated a new wholly owned subsidiary named ‘Cipla Middle East Company’ in the Kingdom of Saudi Arabia, effective March 1, 2026. Cipla Middle East Company has been incorporated with the objective of establishing a legal entity for manufacturing and distribution of pharmaceutical products and hold marketing authorisations in KSA.
Cipla is in the business of manufacturing, developing, and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs).
